Ballmann M, Hartmann H, Deacon C F, Schmidt W E, Conlon J M, Creutzfeldt W
Clin Endocrinol (Oxf). 1986 Oct;25(4):351-61. doi: 10.1111/j.1365-2265.1986.tb01701.x.
A radioimmunoassay using a proinsulin-specific antiserum that does not react preferentially with the split forms of proinsulin has been used to compare the response of circulating proinsulin to low (25 g) and high (75 g) oral glucose loads in healthy subjects and in patients with liver cirrhosis. The patients were divided into two groups: Group A (n = 7) with normal glucose tolerance and Group B with diabetic (n = 5) and impaired (n = 1) glucose tolerance. There was no apparent correlation between glucose tolerance and the results of quantitative liver function tests. In the fasted state, the concentrations of serum proinsulin did not differ significantly in patients of Group A (0.022 +/- 0.002 nmol/l) or Group B (0.026 +/- 0.004 nmol/l) from those in healthy subjects (0.021 +/- 0.002 nmol/l). After 75 g glucose, the rise in serum proinsulin to a maximum concentration of 0.082 +/- 0.012 nmol/l in patients of Group A and to 0.070 +/- 0.019 nmol/l in Group B was not significantly different at any time point up to 180 min from the rise in healthy subjects (to 0.063 +/- 0.005 nmol/l). After 25 g glucose, the response of serum proinsulin in Group B patients (maximum concentration 0.035 +/- 0.003 nmol/l) was not significantly different from that in healthy subjects (maximum concentration 0.032 +/- 0.003 nmol/l) but a slightly enhanced release was observed in the Group A patients (maximum concentration 0.049 +/- 0.003 nmol/l) that was significantly greater (P less than 0.05) at 60 min post-glucose. In contrast, the concentrations of serum immunoreactive insulin and immunoreactive C-peptide in all patients with cirrhosis were significantly elevated compared with healthy subjects both in the fasted state and at several time points following high and low oral glucose. In the fasted state, the serum proinsulin/C-peptide molar ratio, an index of the relative state of secretion of proinsulin and insulin, was significantly lower (P less than 0.05) in both groups of cirrhotic patients than in healthy subjects. After high and low glucose, this ratio fell in all patients and in the healthy subjects. We conclude that cirrhosis of the liver is associated with a hypersecretion of insulin but hyperproinsulinaemia does not contribute appreciably to the elevated concentration of immunoreactive insulin in the peripheral circulation.
一种使用不与胰岛素原裂解形式优先反应的胰岛素原特异性抗血清的放射免疫分析法,已用于比较健康受试者和肝硬化患者中循环胰岛素原对低(25克)和高(75克)口服葡萄糖负荷的反应。患者分为两组:A组(n = 7)糖耐量正常,B组(糖尿病患者n = 5,糖耐量受损患者n = 1)。糖耐量与定量肝功能测试结果之间无明显相关性。在空腹状态下,A组患者(0.022±0.002纳摩尔/升)或B组患者(0.026±0.004纳摩尔/升)的血清胰岛素原浓度与健康受试者(0.021±0.002纳摩尔/升)相比无显著差异。口服75克葡萄糖后,A组患者血清胰岛素原升高至最高浓度0.082±0.012纳摩尔/升,B组患者升高至0.070±0.019纳摩尔/升,在180分钟内的任何时间点,与健康受试者(升高至0.063±0.005纳摩尔/升)相比均无显著差异。口服25克葡萄糖后,B组患者血清胰岛素原的反应(最高浓度0.035±0.003纳摩尔/升)与健康受试者(最高浓度0.032±0.003纳摩尔/升)无显著差异,但A组患者观察到释放略有增强(最高浓度0.049±0.003纳摩尔/升),在葡萄糖摄入后60分钟时显著更高(P小于0.05)。相比之下,所有肝硬化患者在空腹状态以及口服高、低剂量葡萄糖后的几个时间点,血清免疫反应性胰岛素和免疫反应性C肽浓度均显著高于健康受试者。在空腹状态下,作为胰岛素原和胰岛素相对分泌状态指标的血清胰岛素原/C肽摩尔比,在两组肝硬化患者中均显著低于健康受试者(P小于0.05)。口服高、低剂量葡萄糖后,所有患者和健康受试者的该比值均下降。我们得出结论,肝硬化与胰岛素分泌过多有关,但高胰岛素原血症对外周循环中免疫反应性胰岛素浓度升高的贡献不大。